Type 2 Diabetes Medicines Exporter India to USA | City Drug House
City Drug House is a trusted exporter of Noveltreat 0.5 mg (Semaglutide) from India to the USA and Washington. We provide high-quality diabetes medicines with secure packaging, competitive pricing, and timely international delivery for global pharmaceutical buyers.
Noveltreat 0.5 mg (Semaglutide) is a prescription antidiabetic and weight-management medication, launched by Sun Pharma, that functions as a GLP-1 receptor agonist. It is designed for subcutaneous injection, typically administered once weekly to manage Type 2 diabetes and chronic weight management.
Action: It mimics the natural GLP-1 hormone, which increases insulin secretion when blood sugar is high, reduces liver sugar production, and slows gastric emptying to promote satiety (feeling full) and reduce calorie intake.
Weight Loss Support: Aids in long-term weight management by curbing appetite, often resulting in weight loss when combined with diet and exercise.
Cardiovascular Benefits: It is used to reduce the risk of major cardiovascular events (heart attack, stroke) in adults with both type 2 diabetes and heart disease.
Clinical Usage and Description
Indications: Type 2 diabetes management and chronic weight management (for obesity or overweight with comorbidities).
Dosage Form: Pre-filled, , single-use subcutaneous pen (pre-filled syringe/pen).
Administration: Subcutaneous injection (under the skin) once weekly, usually into the abdomen, thigh, or upper arm.
Dosage Cycle: Often used as a maintenance dose after a titration (dose-increase) phase, such as starting from 0.25 mg).
Precautions and Side Effects
Side Effects: Nausea, vomiting, diarrhea, stomach pain, and constipation are common, which often improve over time.
Contraindications: Do not use if you or your family has a history of medullary thyroid cancer (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Restrictions: Not for Type 1 diabetes, typically not for children under 12, and should be stopped 2 months before planned pregnancy.
Storage: Keep stored at 2–8°C
City Drug House Exporters provides:
Bulk supply for hospitals & distributors
Export to USA , Washington, INDIA
Regulatory documents (COA, MSDS, etc.)
Competitive pricing & reliable logistics
Contact for More Information :
📞 Contact City drug House Exporters from India
🌐 Websites: https://www.citydrugexporters.com
📧 Email: citydrug123@gmail.com
📦 Business Type: Exporter | Bulk Supplier | Distributor
📲 WhatsApp: +91 9975390171
City Drug House is a trusted exporter of Noveltreat 0.5 mg (Semaglutide) from India to the USA and Washington. We provide high-quality diabetes medicines with secure packaging, competitive pricing, and timely international delivery for global pharmaceutical buyers.
Noveltreat 0.5 mg (Semaglutide) is a prescription antidiabetic and weight-management medication, launched by Sun Pharma, that functions as a GLP-1 receptor agonist. It is designed for subcutaneous injection, typically administered once weekly to manage Type 2 diabetes and chronic weight management.
Action: It mimics the natural GLP-1 hormone, which increases insulin secretion when blood sugar is high, reduces liver sugar production, and slows gastric emptying to promote satiety (feeling full) and reduce calorie intake.
Weight Loss Support: Aids in long-term weight management by curbing appetite, often resulting in weight loss when combined with diet and exercise.
Cardiovascular Benefits: It is used to reduce the risk of major cardiovascular events (heart attack, stroke) in adults with both type 2 diabetes and heart disease.
Clinical Usage and Description
Indications: Type 2 diabetes management and chronic weight management (for obesity or overweight with comorbidities).
Dosage Form: Pre-filled, , single-use subcutaneous pen (pre-filled syringe/pen).
Administration: Subcutaneous injection (under the skin) once weekly, usually into the abdomen, thigh, or upper arm.
Dosage Cycle: Often used as a maintenance dose after a titration (dose-increase) phase, such as starting from 0.25 mg).
Precautions and Side Effects
Side Effects: Nausea, vomiting, diarrhea, stomach pain, and constipation are common, which often improve over time.
Contraindications: Do not use if you or your family has a history of medullary thyroid cancer (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Restrictions: Not for Type 1 diabetes, typically not for children under 12, and should be stopped 2 months before planned pregnancy.
Storage: Keep stored at 2–8°C
City Drug House Exporters provides:
Bulk supply for hospitals & distributors
Export to USA , Washington, INDIA
Regulatory documents (COA, MSDS, etc.)
Competitive pricing & reliable logistics
Contact for More Information :
📞 Contact City drug House Exporters from India
🌐 Websites: https://www.citydrugexporters.com
📧 Email: citydrug123@gmail.com
📦 Business Type: Exporter | Bulk Supplier | Distributor
📲 WhatsApp: +91 9975390171
Keywords
